FR 
EN 
PT 
DE 
Manufacturing Chemist sat down with CEO Ara Ohanian to discuss Systech’s solution to the counterfeiting and diversion problems running rampant in the pharmaceutical industry. The increase in drug counterfeiting and diversion tells us that compliance alone does not equal patient safety and brand protection.
Read the full article here.
